![Adam C. Derbyshire](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adam C. Derbyshire
Plus aucun poste en cours
Historique de carrière de Adam C. Derbyshire
Anciens postes connus de Adam C. Derbyshire
Sociétés | Poste | Début | Fin |
---|---|---|---|
SALIX PHARMACEUTICALS, LTD. | Directeur Administratif | 01/06/2000 | 05/11/2014 |
Directeur Financier/CFO | 01/06/2000 | 05/11/2014 | |
King Pharmaceuticals Research & Development, Inc. | Comptroller/Controller/Auditor | 01/06/2000 | 01/06/2000 |
Secrétaire Général | 01/06/2000 | 01/06/2000 |
Formation de Adam C. Derbyshire
The University of North Carolina at Wilmington | Undergraduate Degree |
The University of North Carolina at Charlotte | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Administrative Officer | 1 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Salix Pharmaceuticals Ltd.
![]() Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
King Pharmaceuticals Research & Development, Inc. | Health Technology |
- Bourse
- Insiders
- Adam C. Derbyshire
- Expérience